CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Restricted Stock Units	Common Stock	Common Stock Restricted Stock Units	Additional Paid-in Capital	Additional Paid-in Capital Restricted Stock Units	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive Loss	Non-controlling interest in consolidated subsidiaries
Balance, beginning of period (in shares) at Dec. 31, 2020			56,108					20
Balance, beginning of period at Dec. 31, 2020	$ 1,983,018		$ 56		$ 660,771		$ 1,347,880	$ (177)	$ (25,512)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)				248
Equity withheld for employee taxes (in shares)				(84)
Equity withheld for employee taxes		$ (31,935)				$ (31,935)
Stock-based compensation expense	14,624				14,624
Proceeds from stock options exercises (in shares)			109
Exercise of stock options	4,424				4,424
Other comprehensive income (loss)	(15,238)								(15,238)
Net income	109,046						109,046
Balance, end of period (in shares) at Mar. 31, 2021			56,381					20
Balance, end of period at Mar. 31, 2021	2,063,939		$ 56		647,884		1,456,926	$ (177)	(40,750)	0
Balance, beginning of period (in shares) at Dec. 31, 2020			56,108					20
Balance, beginning of period at Dec. 31, 2020	1,983,018		$ 56		660,771		1,347,880	$ (177)	(25,512)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	(3,561)
Net income	223,717
Balance, end of period (in shares) at Jun. 30, 2021			56,613					20
Balance, end of period at Jun. 30, 2021	2,212,668		$ 57		670,264		1,571,597	$ (177)	(29,073)	0
Balance, beginning of period (in shares) at Mar. 31, 2021			56,381					20
Balance, beginning of period at Mar. 31, 2021	2,063,939		$ 56		647,884		1,456,926	$ (177)	(40,750)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)				19
Equity withheld for employee taxes (in shares)				(6)
Equity withheld for employee taxes		(2,631)				(2,631)
Stock-based compensation expense	13,792				13,792
Proceeds from stock options exercises (in shares)			219
Exercise of stock options	11,220		$ 1		11,219
Other comprehensive income (loss)	11,677								11,677
Net income	114,671						114,671
Balance, end of period (in shares) at Jun. 30, 2021			56,613					20
Balance, end of period at Jun. 30, 2021	$ 2,212,668		$ 57		670,264		1,571,597	$ (177)	(29,073)	0
Balance, beginning of period (in shares) at Dec. 31, 2021	56,849		56,849
Balance, beginning of period at Dec. 31, 2021	$ 2,495,837		$ 57		711,912		1,829,532	$ (177)	(54,207)	8,720
Treasury stock, beginning of period (in shares) at Dec. 31, 2021								20
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)				193
Equity withheld for employee taxes (in shares)			(67)
Equity withheld for employee taxes		(18,376)				(18,376)
Stock-based compensation expense	22,702				22,702
Proceeds from stock options exercises (in shares)			158
Exercise of stock options	2,884				2,884
Other comprehensive income (loss)	(31,943)								(31,943)
Purchase of noncontrolling interest	(7,067)									(7,067)
Net income	89,719						89,719
Balance, end of period (in shares) at Mar. 31, 2022			57,133
Balance, end of period at Mar. 31, 2022	$ 2,553,756		$ 57		719,122		1,919,251	$ (177)	(86,150)	1,653
Treasury stock, end of period (in shares) at Mar. 31, 2022								20
Balance, beginning of period (in shares) at Dec. 31, 2021	56,849		56,849
Balance, beginning of period at Dec. 31, 2021	$ 2,495,837		$ 57		711,912		1,829,532	$ (177)	(54,207)	8,720
Treasury stock, beginning of period (in shares) at Dec. 31, 2021								20
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	(22,150)
Net income	$ 108,323
Balance, end of period (in shares) at Jun. 30, 2022	57,353		57,353
Balance, end of period at Jun. 30, 2022	$ 2,624,006		$ 57		760,975		1,937,855	$ (177)	(76,357)	1,653
Treasury stock, end of period (in shares) at Jun. 30, 2022								20
Balance, beginning of period (in shares) at Mar. 31, 2022			57,133
Balance, beginning of period at Mar. 31, 2022	2,553,756		$ 57		719,122		1,919,251	$ (177)	(86,150)	1,653
Treasury stock, beginning of period (in shares) at Mar. 31, 2022								20
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)				24
Equity withheld for employee taxes (in shares)				(6)
Equity withheld for employee taxes		$ (1,843)				$ (1,843)
Stock-based compensation expense	24,902				24,902
Proceeds from stock options exercises (in shares)			147
Exercise of stock options	6,410				6,410
Issuance of common stock from employee stock purchase plan (in shares)			55
Issuance of common stock from employee stock purchase plan	12,384				12,384
Other comprehensive income (loss)	9,793								9,793
Net income	$ 18,604						18,604
Balance, end of period (in shares) at Jun. 30, 2022	57,353		57,353
Balance, end of period at Jun. 30, 2022	$ 2,624,006		$ 57		$ 760,975		$ 1,937,855	$ (177)	$ (76,357)	$ 1,653
Treasury stock, end of period (in shares) at Jun. 30, 2022								20